SanDisk shares have been lately rallying strongly on the back of several positive industry trends. Although SanDisk will take several quarters to outgrow its revenue woes, the bad news has already been baked into the SanDisk stock price. SanDisk’s enterprise SSD segment is growing at a healthy clip and has good potential to pull the…
Aclaris Therapeutics Inc. (NASDAQ: ACRS) expects to raise $75 million in its upcoming IPO. Based in Malvern, Pennsylvania, Aclaris Therapeutics is a clinical-stage specialty pharmaceutical that develops and markets topical treatments to address various dermatological conditions. ACRS will offer 5 million shares at an expected price range of $14 to $16. If the underwriters price the…
The Supreme Court of the United States just recently, correctly decided not to review the US vs Newman Insider Trading case. In response to this decision, there was a well written commentary on the decision here on Bloomberg by Matthew Levine. Given my interest at the near 2 year anniversary of my destroying the SEC…
I want to spend some time here discussing a different way to analyze stock investments and an investment strategy that does not involve trying to find stocks that will go up more in value than the market averages. While I find it very difficult to find stocks that will consistently generate above average capital gains,…
Shares of Advaxis (ADXS) are down 27% in after-hours trade after the company announced that the FDA has placed its HPV program on clinical hold due to one patient death. The stock had dropped as much as 18% today but then had rebounded to -8% at the close. The specific drug placed on hold is…
There are a few pieces to this. First, mortgage credit continues to improve, albeit painfully slowly. This is the reason I’ve been saying for some time now higher rates are needed. Higher rates will increase the availability of credit to other borrowers vs who is getting it now (the lowest credit risk). Demand won’t be…
The benchmarks lie. Many investors, new and experienced alike, are intent upon “beating the Dow” or “beating the S&P,” rather than seeing their capital increase over time. It isn’t that difficult to beat the benchmarks. We’ve done it over 15 years from 1999-2014, and this year, the markets, so far, are down 6% to our…
“Patience, persistence and perspiration make an unbeatable combination for success.” – Napolean Hill The fourth quarter has certainly gotten off to an interesting start. The first two days of trading saw stocks plunge in the early hours only to claw their way back by the close of the market. Friday’s Jobs Report was disappointing to…
Gold and silver had some nice follow through today, while the dollar showed weakness within a recent trading range. We have some potential formations on the charts, but so far nothing seems to complete its development and ‘work’ as we might normally expect. Let’s see if the metals can keep their price rally going. The…
Photo Credit: Frank Farm (Flickr) Check out this week’s Danger Zone interview with Chuck Jaffe of Money Life and Marketwatch.com Some of our most successful Danger Zone warnings have been on overvalued cloud software companies, i.e. Demandware (DWRE) and Splunk (SPLK). This week we’ve identified another highflying cloud company that exhibits many of the problematic traits we saw in DWRE and…
